CDK8 was described as an oncogene in colorectal cancer where it promotes beta‐catenin‐dependent transcription (Firestein et al, 2008; Morris et al, 2008), suggesting that its deletion should inhibit intestinal tumorigenesis. Here, CDK8 is linked to colorectal cancer.